Festoons vs under-eye bags vs tear troughs

Festoons, lower-eyelid bags and tear troughs are different findings. A festoon is a mound or drape at the lower-lid–upper-cheek junction that may combine skin, muscle laxity and fluid; an eye bag often reflects projecting orbital fat or lid tissue; a tear trough is a contour hollow. They can coexist, and filling a hollow, removing fat or tightening skin can worsen another feature if the anatomy is misidentified.¹²

Map location before naming a treatment

The lower eyelid blends into the cheek across several structural boundaries. A shadow can be caused by a hollow, a mound casting shadow, pigment, visible vessels, thin skin or lighting. Swelling can sit in the eyelid, over the cheekbone or more diffusely. A two-dimensional selfie compresses those layers.

Terminology varies in the literature. The practical goal is not winning a label debate; it is describing location, tissue, fluid behavior and contributing layers accurately enough that a proposed treatment has a coherent target.

A history can change the anatomy hypothesis

Ask when the feature appeared; whether it changes morning to evening, with salt, allergy, sleep, heat or illness; whether one side differs; and whether there is pain, redness, eye irritation, vision change or systemic swelling. Record thyroid, kidney, cardiac, sinus, allergy, skin and eye history as clinically relevant.

Prior hyaluronic-acid filler deserves special attention. Delayed periorbital or malar edema can begin weeks to years after treatment, and lymphatic or venous disturbance may contribute.⁴ Retrieve the product, lot, amount, plane, date and injector. “It was dissolved” is incomplete without enzyme product, dose, location and response.

New, persistent, painful, inflamed, asymmetric or vision-associated swelling is not a photo-consultation problem. It needs appropriate clinical evaluation before cosmetic treatment.

Filler can improve one shadow and worsen a fluid problem

Filler may reduce the visual transition of a true infraorbital hollow in selected anatomy. It adds material; it does not remove a fat bag or festoon. In a region prone to edema, product can increase bulk, become visible or contribute to persistent swelling. “Under-eye filler” therefore cannot be prescribed from the presence of darkness alone.

FDA approval is product and indication specific. Some newer fillers have bounded infraorbital-hollow indications, while the general FDA page warns about common and serious filler risks.⁵ Approval for an exact hollow indication is not approval to treat festoons, malar edema or every lower-eyelid feature.

The under-eye approval guide explains how to match product, age, anatomy and labeling. A clinic should identify why added volume is expected to help rather than hide a mound temporarily in selected lighting.

Blepharoplasty does not mean one operation

Lower blepharoplasty can address fat, skin and supporting structures through different approaches. Removing or repositioning fat may change a bag or lid-cheek transition but may not correct a festoon over the cheek. Excess removal can create hollowing or lid-position problems. A surgeon should mark which component each maneuver changes.

Festoons may prompt discussions of skin or muscle tightening, surgical excision, resurfacing, energy devices, sclerosing injections or combinations. The 2026 and earlier reviews emphasize multifactorial anatomy and limited comparative evidence; no universal treatment has emerged.²³ Small series and technique preferences should not be converted into guaranteed correction.

Energy and resurfacing treat surfaces and contraction—not every layer

Laser, radiofrequency, ultrasound, peels and microneedling vary by device, depth and endpoint. They may address texture or induce some contraction, but cannot be assumed to remove orbital fat or resolve fluid. Around the eye, exact device labeling, ocular protection, operator training, skin type and complication plan are central.

Ask what happens if tightening accentuates a hollow or if swelling persists. “Nonsurgical” describes the access route, not the predictability or seriousness of ocular and skin risks.

Outcome photographs need diagnostic labels

A before-and-after gallery should state what was treated, procedure details, time point and whether filler, surgery, resurfacing, weight change or another intervention occurred. Festoons may fluctuate, so a single favorable day is weak evidence. Look for unedited standardized views and consecutive-case outcomes, not only dramatic selections.

Define success by feature: less morning swelling, smoother lid-cheek transition, smaller mound, reduced hollow shadow, better skin texture or improved symmetry. One global “rejuvenated” rating can hide tradeoffs.

Quotes should follow the staged decision tree

The total plan may include eye or medical evaluation, imaging such as ultrasound for prior filler, staged dissolving, filler, surgery, resurfacing and follow-up. Price each branch and its revision or complication policy. Prepaying for a package before the feature is identified reverses the order of care.

1. Name each feature separately Mark hollow, fat projection, mound, fluid, skin and pigment rather than writing “eye bags.”
2. Recover prior-treatment records Product, plane, amount, date, surgery and energy history can change both diagnosis and treatment.
3. Exclude a medical swelling pathway Route new, asymmetric, symptomatic or persistent edema to appropriate evaluation.
4. Assign every maneuver a target Ask what filler, fat repositioning/removal, skin work or energy is supposed to change—and what it may worsen.
5. Use feature-specific follow-up Standardize photos, time of day and expression and track the chosen endpoint across enough time.

The high-value answer is anatomical restraint. Under-eye darkness or puffiness is not one diagnosis, and the best plan may use different tools—or no cosmetic treatment—once the hollow, bag, festoon, fluid and skin components are separated.